Laboratorios Farmaceuticos Rovi Dividends and Buybacks
Dividend criteria checks 3/6
Laboratorios Farmaceuticos Rovi is a dividend paying company with a current yield of 1.53% that is well covered by earnings.
Key information
1.5%
Dividend yield
3.6%
Buyback Yield
| Total Shareholder Yield | 5.1% |
| Future Dividend Yield | 2.3% |
| Dividend Growth | 2.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$1.198 |
| Payout ratio | 39% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: LABF.F's dividend payments have been volatile in the past 10 years.
Growing Dividend: LABF.F's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Laboratorios Farmaceuticos Rovi Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LABF.F) | 1.5% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (LABF.F) (up to 3 years) | 2.3% |
Notable Dividend: LABF.F's dividend (1.53%) is higher than the bottom 25% of dividend payers in the US market (1.43%).
High Dividend: LABF.F's dividend (1.53%) is low compared to the top 25% of dividend payers in the US market (4.31%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (38.9%), LABF.F's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (162.4%), LABF.F's dividend payments are not well covered by cash flows.